We defined the AIM+ cells as OX40+CD137+ for CD4+T cells and CD69+OX137+ for CD8+T cells following the method to identify SRAS-CoV-2 antigen-specific T cells in COVID-19 patients and vaccinated individuals (2, 41). This evidence concerns the gene CD4 and COVID-19.